Digital Angiography-Derived Fractional Flow Assessment for Intracranial Stenosis
Condition(s) studied
Investigational drug(s) / intervention(s)
Standardized medical therapy targeting vascular risk factors and stroke prevention: Dual antiplatelet treatment and management of vascular risk factors, in accordance with AHA/ASA guidelines
Study summary
The goal of this observational study is to learn whether a digital angiography derived fractional flow reserve (DPR) measurement can improve the prediction of stroke risk in adults with symptomatic intracranial atherosclerotic stenosis, defined as 50 to 99 percent narrowing.
The main questions it aims to answer are:
Does DPR identify patients who are at higher risk of recurrent stroke despite receiving standard medical treatment? Is DPR more accurate than traditional angiographic stenosis measurements for assessing the functional severity of intracranial arterial disease?
Participants will undergo routine digital subtraction angiography as part of their clinical evaluation. Their angiographic images will be analyzed using a computational method to estimate blood flow impairment, and they will be followed for up to 12 months to monitor stroke related outcomes.
Eligibility
Primary outcome measure(s)
- ischemic stroke in the qualifying artery territory or related death within 1 year after enrollment. — Baseline to 12 months (±2 months)
the number of participants who suffer from ischemic stroke in the qualifying artery territory or related death within 1 year after enrollment.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Neurosurgery, Xuanwu hospital | Beijing | Xicheng District |
More Xuanwu Hospital, Beijing trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07309705 on ClinicalTrials.gov ↗ ← All trials in China